These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4176081)

  • 41. [Research on calcium pyrrolidinecarboxylate: comparative test with calcium chloride, calcium glutamate, calcium gluconate, calcium lactate and calcium levulinate].
    Marmo E; Matera A; Caputi A; Ungaro B
    Farmaco Prat; 1971 Mar; 26(3):144-85. PubMed ID: 4994417
    [No Abstract]   [Full Text] [Related]  

  • 42. [Thrombogenicity of a new prothrombin complex concentrate].
    Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of the parasympathetic division of the autonomic nervous system in regulating blood coagulation and fibrinolysis following intravenous injection of thrombin].
    Zagrebina LA
    Fiziol Zh SSSR Im I M Sechenova; 1981 Feb; 67(2):235-41. PubMed ID: 7215586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of N-(2-diethylaminoethyl)-N-(2-hydroxy-2-phenylethyl)-2,5-dichloroaniline (AN162) on platelet function and blood coagulation.
    Mac Kenzie RD; Blohm TR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):577-87. PubMed ID: 5004226
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of coagulation factors on intrinsic thrombin generation.
    Stief TW; Otto S; Renz H
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):67-71. PubMed ID: 17179830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antiheparin properties of synthetic polycations].
    Dubovik VV; Etlis VS; Baluda VP; Sushkevich GN; Shevchuk AS
    Farmakol Toksikol; 1975; 38(2):193-8. PubMed ID: 1227887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coagulation studies after administration of a fat emulsion, intralipid.
    Cronberg S; Nilsson IM
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):664-9. PubMed ID: 4968853
    [No Abstract]   [Full Text] [Related]  

  • 48. Retraction and firmness of the fibrin clot.
    Farská I
    Physiol Bohemoslov; 1966; 15(1):79-87. PubMed ID: 4222574
    [No Abstract]   [Full Text] [Related]  

  • 49. The recalcified coagulation activity.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):447-53. PubMed ID: 18160574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering.
    Laidmäe I; McCormick ME; Herod JL; Pastore JJ; Salum T; Sawyer ES; Janmey PA; Uibo R
    Biomaterials; 2006 Dec; 27(34):5771-9. PubMed ID: 16919721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of factor XII (Hagemann's) in activation of the blood anticoagulation system].
    Kudriashov BA; Kalishevskaia TM; Baskova IP; Strukova SM; Kovaleva TN
    Vopr Med Khim; 1969; 15(5):486-94. PubMed ID: 5368086
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of adrenal gland hormones on the thrombogenic properties of the blood in experimental hypercholesteremia in rabbits].
    Rassokhin VM; Shershevskiĭ MG
    Patol Fiziol Eksp Ter; 1966; 10(6):80-1. PubMed ID: 5246530
    [No Abstract]   [Full Text] [Related]  

  • 53. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of infusing thrombin and its acetylated derivative. I. Studies of coagulation and fibrinolysis.
    Pechet L; Engel AM; Goldstein C; Glaser B
    Thromb Diath Haemorrh; 1968 Nov; 20(1):190-201. PubMed ID: 5751381
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 56. A simple gravimetric method for estimation of plasma fibrinogen.
    Saxena KK; Srivastava RK; Kulshrestha VK; Prasad DN
    Indian J Physiol Pharmacol; 1979; 23(2):137-9. PubMed ID: 489096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of Arvin on blood coagulation].
    Vinazzer H
    Wien Z Inn Med; 1971; 52(8):378-92. PubMed ID: 5110844
    [No Abstract]   [Full Text] [Related]  

  • 58. A possible rôle of leukocytes in hemostasis.
    Guest MM; Bond TP; Crawford MA
    Bibl Anat; 1973; 12():131-7. PubMed ID: 4790341
    [No Abstract]   [Full Text] [Related]  

  • 59. [Biological half-life of 131 I-labeled fibrinogen from normal and cobalt-treated rabbits].
    Krantz S; Lober M; Oppermann P
    Acta Biol Med Ger; 1972; 29(6):805-10. PubMed ID: 4659761
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.